These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22143060)

  • 41. Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia.
    Sagatys EM; Zhang L
    Cancer Control; 2012 Jan; 19(1):18-25. PubMed ID: 22143059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative efficacy of first-line therapies for advanced-stage chronic lymphocytic leukemia: a multiple-treatment meta-analysis.
    Terasawa T; Trikalinos NA; Djulbegovic B; Trikalinos TA
    Cancer Treat Rev; 2013 Jun; 39(4):340-9. PubMed ID: 22703832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic lymphocytic leukemia.
    Ghia P; Ferreri AM; Caligaris-Cappio F
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):234-46. PubMed ID: 17544290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of B-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy.
    Faderl S; Ferrajoli A; Frankfurt O; Pettitt A
    Leukemia; 2009 Mar; 23(3):457-66. PubMed ID: 18987653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemoimmunotherapy of chronic lymphocytic leukemia.
    Tam CS; Keating MJ
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):479-98. PubMed ID: 17707835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic markers and standard management of chronic lymphocytic leukemia.
    Stilgenbauer S
    Hematology Am Soc Hematol Educ Program; 2015; 2015():368-77. PubMed ID: 26637745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibody therapy for chronic lymphocytic leukemia: a promising new modality.
    Lin TS; Moran M; Lucas M; Waymer S; Jefferson S; Fischer DB; Grever MR; Byrd JC
    Hematol Oncol Clin North Am; 2004 Aug; 18(4):895-913, ix-x. PubMed ID: 15325705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic and predictive significance of smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.
    Gogia A; Raina V; Gupta R; Gajendra S; Kumar L; Sharma A; Kumar R; Vishnubhatla S
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):514-7. PubMed ID: 24656596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia.
    Robak T; Blonski JZ; Robak P
    Semin Oncol; 2016 Apr; 43(2):280-90. PubMed ID: 27040707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.
    Zaja F; Mian M; Volpetti S; Visco C; Sissa C; Nichele I; Castelli M; Ambrosetti A; Puglisi S; Fanin R; Cortelazzo S; Pizzolo G; Trentin L; Rodeghiero F; Paolini R; Vivaldi P; Sancetta R; Isola M; Semenzato G
    Am J Hematol; 2013 Nov; 88(11):955-60. PubMed ID: 23861234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rituximab in chronic lymphocytic leukemia.
    Jaglowski SM; Byrd JC
    Semin Hematol; 2010 Apr; 47(2):156-69. PubMed ID: 20350663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
    Maddocks K; Jones JA
    Semin Oncol; 2016 Apr; 43(2):251-9. PubMed ID: 27040703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
    Molica S; De Rossi G; Luciani M; Levato D
    Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic lymphocytic leukemia: present status.
    Montserrat E; Rozman C
    Ann Oncol; 1995 Mar; 6(3):219-35. PubMed ID: 7612488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia.
    Shanafelt TD; Byrd JC; Call TG; Zent CS; Kay NE
    Ann Intern Med; 2006 Sep; 145(6):435-47. PubMed ID: 16983131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.
    Cheson BD; Bennett JM; Rai KR; Grever MR; Kay NE; Schiffer CA; Oken MM; Keating MJ; Boldt DH; Kempin SJ
    Am J Hematol; 1988 Nov; 29(3):152-63. PubMed ID: 3189311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Update on chronic lymphocytic leukemia: overview of new agents and comparative analysis.
    Kempin S
    Curr Treat Options Oncol; 2013 Jun; 14(2):144-55. PubMed ID: 23494726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CLL update 2022: A continuing evolution in care.
    Kay NE; Hampel PJ; Van Dyke DL; Parikh SA
    Blood Rev; 2022 Jul; 54():100930. PubMed ID: 35151528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New angles of attack in the fight against chronic lymphocytic leukemia: the advent of novel non-chemotherapeutic agents.
    Bazargan A; Tam CS
    Leuk Lymphoma; 2010 Sep; 51(9):1596-611. PubMed ID: 20578824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.